首页> 外文会议>NATO Advanced Research Workshop on The Plant Cytoskeleton >ANTIMITOTIC DRUGS FOR MICROPROTOPLAST-MEDIATED CHROMOSOME TRANSFER IN PLANT GENOMICS, CELL ENGINEERING AND BREEDING
【24h】

ANTIMITOTIC DRUGS FOR MICROPROTOPLAST-MEDIATED CHROMOSOME TRANSFER IN PLANT GENOMICS, CELL ENGINEERING AND BREEDING

机译:微蛋白微蛋白介导的抗体药物介导的植物基因组学,细胞工程和育种染色体转移

获取原文

摘要

Achievements of the microprotoplast-mediated chromosome transfer (MMCT) technique are summarized. Overcoming technical barriers for large-scale gene transfer through fusion of isolated microprotoplasts, containing one or a few chromosomes, with recipient protoplasts are considered. The efficiency of antimicrotubular compounds - phosphorothioamides (amiprophos-methyl and cremart), dinitroanilines (oryzalin) and propyzamide -and disrupters of microtubule organizing centers (griseofulvin and phenyl-carbamates) for the production of microprotoplasts is analysed. The combined use of antimicrotubular compounds with cytochalasin B, as an actin filament disrupter, for increasing the yield of microprotoplasts is also discussed. Results of experiments using microprotoplasts obtained from plant micro-spores are presented. The paper also discusses the advantages of MMCT as an effective technique for parasexual crossing compared with traditional somatic hybridization and as an important technique for plant genomics and breeding .
机译:所述microprotoplast介导的染色体转移(MMCT)技术的成果进行了总结。考虑含有一个或多种染色体的分离的微蛋白质融合,克服大规模基因转移的技术障碍。分析了抗微生卟啉化合物 - 磷噻嗪(Amiprophos-甲基和Cremart),二硝基甲酰胺(Oryzalin)和丙嘧啶的效率 - 以及微管组织中心(Griseofulvin和苯基 - 氨基甲酸酯)的破坏者进行微蛋白质的产生。还讨论了抗微生卟啉化合物的结合使用抗菌药物B,作为actin灯丝欠压,用于增加微蛋白质的产率。提出了使用从植物微孢子获得的微蛋白质的实验结果。本文还讨论了MMCT作为与传统的体细胞杂交相比的假释交叉的有效技术的优势,作为植物基因组学和育种的重要技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号